Oncological safety of nipple-sparing mastectomy in young patients with breast cancer compared with conventional mastectomy

Oncological safety of nipple-sparing mastectomy in young patients with breast cancer compared with conventional mastectomy

Although nipple-sparing mastectomy (NSM) is being used more frequently, the oncological safety of NSM remains unclear, particularly in young patients (0.05). Following adjustment for clinical stage, the LR and DFS rates between the two groups exhibited no significant differences. Analysis of the pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology letters 2018-04, Vol.15 (4), p.4813-4820
Hauptverfasser: Huang, Jiapeng, Mo, Qinguo, Zhuang, Yaqiang, Qin, Qinghong, Huang, Zhen, Mo, Junyang, Tan, Qixing, Lian, Bin, Cao, Yiming, Qin, Shuting, Wei, Changyuan
Format: Artikel
Sprache:eng
Schlagworte:
Age
Biopsy
Breast cancer
Cancer therapies
Care and treatment
Comparative analysis
Epidermal growth factor
Health aspects
Lymphatic system
Mammography
Mastectomy
Medical prognosis
Metastasis
Mortality
Multivariate analysis
Oncology
Patients
Quality of life
Studies
Surgery
Survival analysis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Although nipple-sparing mastectomy (NSM) is being used more frequently, the oncological safety of NSM remains unclear, particularly in young patients (0.05). Following adjustment for clinical stage, the LR and DFS rates between the two groups exhibited no significant differences. Analysis of the prognostic factors demonstrated that clinical stage, lymph node status, estrogen and progesterone receptor status and human epidermal growth factor receptor 2 status were associated with DFS (P
ISSN:1792-1074
1792-1082
DOI:10.3892/ol.2018.7913